Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market

Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market

Submitted by admin on September 24, 2018 - 3:34pm
Source: 
CP Wire
News Tags: 
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
head and neck cancer
Headline: 
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
snippet: 

Innovation Pharmaceuticals (OTCQB:IPIX)announced on 9/24/18 the publication of a comparative perspective on the development of Brilacidin for the prevention of severe Oral Mucositis (SOM) in Head and Neck Cancer (HNC). 

Do Not Allow Advertisers to Use My Personal information